Quantapore Inc. was founded in 2009

around a core group of scientists with various backgrounds.













Martin Huber, Ph.D. - CEO
Dr.Huber is a co-founder of Quantapore and the inventor of Quantapore's NPS technology.
Dr. Huber holds an M.S. and a Ph.D. in Genetics and Biochemistry (cum laude) from the University of Vienna, Austria. He has over 15 years of experience in biotechnology start-ups both in Europe and the US. During this time he held positions of increasing responsibilities and was involved in the product development process from early feasibility experiments to successful product launches.


Sascha C. Dennstedt, MD, MSc - President
Dr. Dennstedt is a co-founder of Quantapore and responsible for business planning and development efforts as well as managing early-stage operations. Dr. Dennstedt is an experienced entrepreneur and has successfully invested in multiple Biotech start-ups as well as in other commercial enterprises.


Deryl C. Banks - CFO
Mr. Banks has over 25 years experience in finance, accounting and human resource management.  He started and managed finance departments at four medical device start-ups spanning 15 years and helped raise and manage over $120M in venture capital and debt funding.  He is currently the Life Science Practice Leader at The Brenner Group and serves as interim CFO for emerging medical device companies.



Reading the human genome.


Quantapore Inc. 2011